Legislature(2013 - 2014)CAPITOL 106
04/08/2014 03:00 PM House HEALTH & SOCIAL SERVICES
| Audio | Topic |
|---|---|
| Start | |
| SB169 | |
| HB90 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| += | SB 169 | TELECONFERENCED | |
| += | HB 90 | TELECONFERENCED | |
| + | TELECONFERENCED |
HB 90-TESTING NEWBORNS FOR VITAMIN D
3:16:43 PM
CHAIR HIGGINS announced that the next order of business would be
HOUSE BILL NO. 90, "An Act establishing a temporary program in
the Department of Health and Social Services for testing
newborns for baseline vitamin D levels." [In front of the
committee was the proposed committee substitute (CS) for HB 90,
labeled 28-LS0376\O, Mischel, 2/4/14, adopted as the working
draft on February 6, 2014.]
REPRESENTATIVE KELLER moved to adopt the proposed committee
substitute (CS) for HB 90, labeled 28-LS0376\Y, Mischel,
3/31/14, as the working draft. There being no objection, it was
so ordered.
REPRESENTATIVE SEATON, as the sponsor of the bill, explained the
changes to Version Y, reporting that these changes were made in
response to suggestions from the House Health and Social
Services Standing Committee. He noted that the original
proposal had been for statewide universal testing for one year
with an opt out option, and that the research did not direct any
immediate benefit for the newborns or the mothers. He explained
that Version Y would make this a two year pilot project for 500
volunteer pregnant women. He was discussing involvement with
various providers to become the coordinating local entity and to
provide program analysis and data for the participants benefit.
He reported that this would become a project based on the
application of medical science to collect the information on
pregnancies in Alaska and to provide medical benefits for
mothers and newborns. He pointed out that a similar project in
South Carolina had reduced the pre-term births to 7 percent,
which would equate to a reduction of 25 pre-term births in
Alaska and a savings of $1.3 million. He shared that the state
would have a maximum match with the partners of 20 percent,
about $100,000. He referred to the Protect Our Children Now
program description and cost schedule. [Included in members'
packets] He stated that this would move the population forward
in prevention of unintended pregnancy outcomes. He asked that
the committee move the bill forward.
3:23:08 PM
CHAIR HIGGINS asked for clarification that the end goal for the
program was for documentation proving that Vitamin D does what
Representative Seaton had presented, and to encourage its use.
REPRESENTATIVE SEATON expressed his agreement, reiterating that
this was a voluntary demonstration project and that, should the
results support it, the medical community would encourage the
use of Vitamin D.
CHAIR HIGGINS asked about the study in Australia.
REPRESENTATIVE SEATON clarified that the proposed program,
Protect Our Children Now, was based on a South Carolina study.
He opined that the program could lower pre-term births in
Alaska.
3:25:37 PM
REPRESENTATIVE SEATON, in response to Chair Higgins, said that
the South Carolina study had been conducted since 2004, and had
begun as a research project. He said that the proposed program
for Alaska was an outgrowth of this project.
CHAIR HIGGINS reflected on a recent seminar he had attended
which discussed studies and research. He offered an anecdote
claiming that a two year study was useless and needed to be
drawn out over a much longer period, and that the performance of
the studies often made the research useless. He pointed out
that the proposed bill was for a two-year study, yet he opined
that it was necessary for a longer research project to fully
understand the data.
REPRESENTATIVE SEATON expressed his agreement. He pointed out
that the aforementioned had been a research study, while this
was a project based on that research. He noted that pregnancy
outcomes were recognized in 9 months, and it would require about
500 pregnancies for enough data to review the pre-term birth
rate. He declared that the proposed bill was for a project
based on scientific research, and although it would offer more
data, was not a research project.
3:30:17 PM
REPRESENTATIVE SEATON pointed out that the fiscal note from
Department of Health and Social Services was higher than
permitted by the proposed bill, and he relayed that there was a
search for a different partner to do this more economically. He
mentioned partners in other states performing this program for
much less than the attached fiscal note proposed. He shared
that the proposed bill would show a willingness by the State of
Alaska to participate in the improvement of the health of
pregnant women and infants. He reiterated that this was a pilot
project, implementing earlier research findings from other
studies.
3:31:19 PM
REPRESENTATIVE TARR referred to other screenings, and asked if
any of them would be willing to incorporate questions about
Vitamin D use.
REPRESENTATIVE SEATON replied that this would be part of the
nutritional and screening information compiled from those who
volunteered to be in the program. He clarified that the project
was not designed for a questionnaire, but would focus on better
outcomes and healthier mothers and newborns. The proposed bill
would show that the state would be willing to participate as a
minor partner.
3:33:37 PM
CHAIR HIGGINS stated that public testimony was still open.
3:33:55 PM
STEPHANIE WRIGHTSMAN-BIRCH, Chief, Women, Children & Family
Health, Division of Public Health, Department of Health and
Social Services, stated appreciation for the changes to Version
Y, especially as it included treatment and public information
after the data had been collected. She expressed concerns with
the content of the bill as it pointed toward conducting an
experimentally designed research study which would be the
responsibility of the Division of Public Health to carry
forward. She stated that this was not a core function of
Division of Public Health. She acknowledged that participation
was voluntary, although she opined that all research was
voluntary. She stated that a longer time was necessary to
collect the data. She declared that DHSS was very sensitive to
requiring Institutional Review Board (IRB) approvals. She noted
that there were rigorous study design elements and national
standards that needed to be adhered. She noted that the
proposed fiscal note included state personnel time for
administration, and even if the intent was for a contractor and
a grantee, it was the responsibility of the Division of Public
Health to oversee the study design and protocol, and to conduct
a secondary review of the data. She declared that there were
costs included for this. Once the data was collected and
analyzed, it had to be compared with prior research and
recommendations. She declared a challenge to be the lack of
acceptable standard recommendations or guidelines for Vitamin D
levels on newborns or pregnant women. She acknowledged a
difference of opinion between the Vitamin D literature and the
recommendations for its use by organizations to which public
health officials were bound to follow.
3:39:09 PM
CHAIR HIGGINS closed public testimony and took a brief at-ease.
3:39:45 PM
REPRESENTATIVE KELLER moved to report the proposed committee
substitute (CS) for HB 90, labeled 28-LS0376\Y, Mischel,
3/31/14, out of committee with individual recommendations and
the attached fiscal notes. There being no objection, CSHB
90(HSS) was moved from the House Health and Social Services
Standing Committee.
3:39:58 PM
The committee took a brief at-ease.
3:42:11 PM
ADJOURNMENT
There being no further business before the committee, the House
Health and Social Services Standing Committee meeting was
adjourned at 3:42 p.m.
| Document Name | Date/Time | Subjects |
|---|---|---|
| HB090 sponsor statement- 2014.pdf |
HHSS 4/8/2014 3:00:00 PM |
HB 90 |
| HB090 draft proposed CS Ver 28-LS0376Y.pdf |
HHSS 4/8/2014 3:00:00 PM |
HB 90 |
| HB090 changes-ver O to ver Y.pdf |
HHSS 4/8/2014 3:00:00 PM |
HB 90 |
| Alaska Vaccine Letter Medicaid FINAL 4-7-14.pdf |
HHSS 4/8/2014 3:00:00 PM |
|
| HB090 Support Document-study-Wagner-2013.pdf |
HHSS 2/6/2014 3:00:00 PM HHSS 4/8/2014 3:00:00 PM |
HB 90 |
| HB090 Support Document-Protect our Children Now-booklet 2-3-14_grassroots.pdf |
HHSS 2/6/2014 3:00:00 PM HHSS 4/8/2014 3:00:00 PM |
HB 90 |
| HCS for CSSB 169 ver T Section Analysis.pdf |
HHSS 4/3/2014 3:00:00 PM HHSS 4/8/2014 3:00:00 PM |
SB 169 |
| HCS for CSSB 169 ver T Explanation of Changes.pdf |
HHSS 4/3/2014 3:00:00 PM HHSS 4/8/2014 3:00:00 PM |
SB 169 |
| CS SB 169 Version T.pdf |
HHSS 4/3/2014 3:00:00 PM HHSS 4/8/2014 3:00:00 PM |
SB 169 |
| SB169 WhoPaysFor VaccineInAK.pdf |
HHSS 4/8/2014 3:00:00 PM SHSS 2/21/2014 1:30:00 PM |
SB 169 |
| SB 169 DCCED fiscal note.pdf |
HHSS 4/8/2014 3:00:00 PM SHSS 2/21/2014 1:30:00 PM |
SB 169 |
| SB 169 DHSS fiscal note #2.pdf |
HHSS 4/8/2014 3:00:00 PM SHSS 2/21/2014 1:30:00 PM |
SB 169 |
| SB 169 DHSS fiscal note.pdf |
HHSS 4/8/2014 3:00:00 PM SHSS 2/21/2014 1:30:00 PM |
SB 169 |
| SB 169 DOA fiscal note.pdf |
HHSS 4/8/2014 3:00:00 PM SHSS 2/21/2014 1:30:00 PM |
SB 169 |
| SB 169 Fund Transfers fiscal note.pdf |
HHSS 4/8/2014 3:00:00 PM SHSS 2/21/2014 1:30:00 PM |
SB 169 |
| SB169 Sponsor Statement Immunization Program.pdf |
HHSS 4/8/2014 3:00:00 PM SHSS 2/21/2014 1:30:00 PM |
SB 169 |
| House CSSB 169 Version D.pdf |
HHSS 4/8/2014 3:00:00 PM |
SB 169 |
| HCS for CSSB 169 ver D Section Analysis.pdf |
HHSS 4/8/2014 3:00:00 PM |
SB 169 |
| HCS for CSSB 169 ver D Explanation of Changes.pdf |
HHSS 4/8/2014 3:00:00 PM |
SB 169 |